← Ranking

CSX · CSX CORP

No alerts · No concrete new risks or important recent events

10-Q 2026-07-22 ↗ compared with the reference 10-K 10-K 2026-02-12 ↗

Closing price50-day average200-day average

Technical events and factor profile →

Summary

Csx adds $5 billion to its share repurchase program, expanding its authority from October 2023. The company also discloses new data on its stock performance for the second quarter of 2026.

Automatic summary generated from the filing; it may contain inaccuracies.
Concrete new risks
—
Generic new risks
—
Filing
10-Q · 2026-07-22

How the stock reacted

After the 10-Q1 session5 sessions20 sessions
CSX+0.1%+1.9%+0.7%
Nasdaq-100 (QQQ)-0.5%-4.7%+1.2%
Difference+0.6%+6.6%-0.5%

From the close before the filing. Historical data, not a prediction.

Key figures quarterly · USD

Revenue (TTM)
$14.5B
YoY growth
+10.1%
Operating margin
38.3%
Cash / debt
$1.0B / $9.8B
Jun 26Mar 26Dec 25Sep 25Jun 25
Revenue$3.9B$3.5B$3.5B$3.6B$3.6B
YoY growth+10.1%+1.7%-0.9%-0.9%-3.4%
Gross margin—————
Operating margin38.3%36.0%31.6%30.3%35.9%
Net income$1.0B$807M$720M$694M$829M
Diluted EPS0.540.430.390.370.44

XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.

Factor profile percentile vs. the S&P 500 and the Nasdaq-100

Momentum
12 months excl. last: +33.9% · 6 months +13.0%
78
Trend quality
R² 0.33 · rising
70
Relative strength
+2.9% vs. the S&P 500 over 6 months
74
Volatility
21% annualised
17
Beta
beta 0.43
43
Distance from high
-8.3% from the 52-week high
71
Extension
+2.0 standard deviations from its 20-day average
76

0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors

Management tone MD&A

+15

More optimistic than in the previous 10-Q (2026-04-22: +8, +7 points)

10-Q of 2026-07-22 · 31.1% positive sentences, 15.6% negative · 167 sentences analysed

Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.

Top funds 13F

Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier
0.4% $106.0M -6%
Markel Group · Tom Gayner
held since Q2 2025
0.2% $27.8M +10%
Viking Global · Andreas Halvorsen — sold

Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.

Recent material events (8-K)

2026-10-13 Executive or board changesInvestor communication (Reg FD) SEC ↗
2026-07-22 Results released 5 sessions: +7.8% vs Nasdaq-100 SEC ↗

All material events for CSX →

Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.